Relationship between the nutritional status and safety and efficacy outcomes in atrial fibrillation patients aged 80 years and over receiving oral anticoagulants

被引:9
|
作者
Shinohara, Masaya [1 ]
Wada, Ryo [1 ]
Yano, Kensuke [1 ]
Akitsu, Katsuya [1 ]
Koike, Hideki [1 ]
Kinoshita, Toshio [1 ]
Fujino, Tadashi [1 ]
Ikeda, Takanori [1 ]
机构
[1] Toho Univ, Dept Cardiovasc Med, Fac Med, Tokyo, Japan
关键词
Nutritional status; Atrial fibrillation; Oral anticoagulants; SERUM-ALBUMIN; RISK; DEFINITION; WARFARIN; FRAILTY; STROKE; HEALTH; IMPACT; INDEX;
D O I
10.1016/j.jjcc.2020.10.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Malnutrition has been reported to be associated with worse clinical outcomes in various cardiovascular diseases. We aimed to investigate the clinical significance of the nutritional status in atrial fibrillation (AF) patients aged 80 years and over receiving oral anticoagulants (OACs), focusing on the difference between direct OACs (DOACs) and warfarin treatment. Methods: This was a retrospective and observational study. We enrolled 332 consecutive AF patients aged 80 years and over who were treated with OACs: DOACs (n = 256) and warfarin (n = 76). A controlling nutritional status (CONUT) score was used to evaluate the nutritional status. The enrolled patients were divided into two groups based on the CONUT score: CONUT score <5 (n = 239) and CONUT score >= 5 (n = 93) groups. We investigated the relationship between the nutritional status and clinical outcomes. Results: The CONUT score >= 5 group had significantly higher incidence of major bleeding (MB) compared to the CONUT score <5 group (4.6/100 person-years vs. 0.7/100 person-years, p < 0.01). On Cox hazard analysis, CONUT score >= 5 group was significantly associated with increased MB compared with the CONUT score <5 group (hazard ratio: 5.80, 95% confidence interval: 1.44-23.33, p = 0.013). In the DOAC group, the incidence of MB did not differ between the CONUT score >= 5 and CONUT score <5 groups (p = 0.54). In the warfarin group, MB occurred more frequently in the CONUT score >= 5 group than CONUT score <5 group (p < 0.01). There was no significant difference in the incidence of thromboembolic events between the CONUT score >= 5 and CONUT score <5 groups in both the DOAC and warfarin groups. Conclusions: The prognostic values of the nutritional status based on the CONUT score for MB differed between AF patients aged 80 years and over receiving DOACs and those receiving warfarin. It may be favorable to use DOACs to avoid bleeding events in those with malnutrition. (C) 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 50 条
  • [1] Relationship between the degree of renal dysfunction and the safety and efficacy outcomes in patients with atrial fibrillation receiving direct oral anticoagulants
    Wada, Ryo
    Shinohara, Masaya
    Nakanishi, Rine
    Kinosihita, Toshio
    Yuzawa, Hitomi
    Ikeda, Takanori
    JOURNAL OF ARRHYTHMIA, 2021, 37 (01) : 88 - 96
  • [2] Direct oral anticoagulants for patients aged over 80 years in nonvalvular atrial fibrillation: the impact of frailty
    De Simone, Vincenzo
    Mugnolo, Antonio
    Zanotto, Gabriele
    Morando, Giorgio
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2020, 21 (08) : 562 - 569
  • [3] Direct oral anticoagulants in atrial fibrillation patients aged 75 years or older: Efficacy and safety balance
    Fomin, V. V.
    Svistunov, A. A.
    Napalkov, D. A.
    Sokolova, A. A.
    Gabitova, M. A.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (04) : 4 - 7
  • [4] Efficacy and Safety Outcomes of Direct Oral Anticoagulants and Amiodarone in Patients with Atrial Fibrillation
    Lupercio, Florentino
    Romero, Jorge
    Peltzer, Bradley
    Maraboto, Carola
    Briceno, David
    Villablanca, Pedro
    Ferrick, Kevin
    Gross, Jay N.
    Kim, Soo
    Fisher, John
    Di Biase, Luigi
    Krumerman, Andrew
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (05): : 573.e1 - 573.e8
  • [5] Effectiveness and safety of oral anticoagulants in patients aged 90 years or older with atrial fibrillation
    Giustozzi, M. G.
    Vedovati, M. C.
    Verso, M.
    Conti, S.
    Verdecchia, P.
    Bogliari, G.
    Pierpaoli, L.
    Agnelli, G.
    Becattini, C.
    EUROPEAN HEART JOURNAL, 2018, 39 : 441 - 441
  • [6] Efficacy and safety of atrial fibrillation ablation in patients with aged 80 years or older
    Yodogawa, Kenji
    Iwasaki, Yu-ki
    Ito, Nobuaki
    Arai, Toshiki
    Hachisuka, Masato
    Fujimoto, Yuhi
    Hagiwara, Kanako
    Murata, Hiroshige
    Aizawa, Yoshiyasu
    Shimizu, Wataru
    Asai, Kuniya
    HEART AND VESSELS, 2025, 40 (03) : 245 - 250
  • [7] Evaluation of oral anticoagulants in atrial fibrillation patients over 80 years of age with nonsevere frailty
    Noro, Mahito
    JOURNAL OF ARRHYTHMIA, 2019, 35 (06) : 804 - 804
  • [8] Efficacy and safety of atrial fibrillation ablation in patients aged ≥80 years: a retrospective study
    Sakamoto, Yusuke
    Osanai, Hiroyuki
    Tanaka, Yuki
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2025, 87 (01) : 37 - 50
  • [9] Comparative Efficacy and Safety of New Oral Anticoagulants in Patients With Atrial Fibrillation
    Schneeweiss, Sebastian
    Gagne, Joshua J.
    Patrick, Amanda R.
    Choudhry, Niteesh K.
    Avorn, Jerry
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (04): : 480 - 486
  • [10] Direct Oral Anticoagulants and Non-valvular Atrial Fibrillation: Compliance with Dose Level Guidelines in Patients Aged 80 Years and Over
    Marie Cavillon Decaestecker
    Laurie Ferret
    Kevin Decaestecker
    Sophie Gautier
    Stéphane Verdun
    Essé Sylvestre Tsogli
    Drugs & Aging, 2021, 38 : 939 - 950